Posts  / #POST-225848
BLOG

Hedge funds' best ideas #93 - Q1'26 Pitches

S
Apr 29, 2026 · 15:22

<div class="subscription-widget-wrap-editor"><div class="subscription-widget show-subscribe"><div class="preamble"><p class="cta-caption">Thanks for reading Stock Analysis Compilation! Subscribe for free to receive new posts and support my work.</p></div><form class="subscription-widget-subscribe"><input class="email-input" name="email" tabindex="-1" type="email" /><input class="button primary" type="submit" value="Subscribe" /><div class="fake-input-wrapper"><div class="fake-input"></div><div class="fake-button"></div></div></form></div></div><div><hr /></div><h3><strong>Upgrade Your Edge on HFBestIdeas.com</strong> &#128640;</h3><p>Stop spending hours sourcing and digesting Hedge Fund letters. Let HFBestIdeas do the manual work for you and turn over more rocks in less time. </p><p><strong>Try any premium plan free for 7 days:</strong></p><ul><li><p><strong>The Analyst ($10/mo):</strong> Full newsletter (35+ stock pitches/week).</p></li><li><p><strong>The Associate ($19/mo):</strong> Full access to our pitch database + Quarterly Letter archive.</p></li><li><p><strong>The Rainmaker ($29/mo):</strong> Total access + <strong>Warren AI</strong>, your proprietary research assistant.</p></li></ul><p><em>Note: For Associate &amp; Rainmaker access, please subscribe directly at <a href="https://HFBestIdeas.com">HFBestIdeas.com</a>.</em></p><p class="button-wrapper"><a class="button primary" href="https://www.hfbestideas.com/pricing"><span>Start Your 7-Day Free Trial</span></a></p><p>Now, let&#8217;s get into this week&#8217;s selection of fund ideas &#128071;</p><div><hr /></div><h3>Summary :</h3><p>&#128313; AJ Bell plc (AJB LN) by Vltava Fund</p><p>&#128313; AUB Group Limited (AUB AU) by Ganes Focused Value Fund</p><p>&#128313; Bayer AG (BAYN GY) by Ariel Global</p><p>&#128313; Becle S.A.B. de C.V. (CUERVO* MM) by Longleaf Partners Small Cap Fund</p><p>&#128313; Bio-Rad Laboratories Inc. (BIO US) by Ariel Focused Value</p><p>&#128313; Coupang, Inc. (CPNG US) by Oakmark International Fund</p><p>&#128313; Cushman &amp; Wakefield plc (CWK US) by Riverwater Small Cap Strategy</p><p>&#128313; DTS Corporation (9682 JP) by Oakmark International Small Cap Fund</p><p>&#128313; ENGIE SA (ENGI FP) by Ariel Global</p><p>&#128313; FactSet Research Systems Inc. (FDS US) by Ariel Focused Value</p><p>&#128313; Fair Isaac Corporation (FICO US) by Bristlemoon Capital</p><p>&#128313; GE Vernova Inc (GEV US) by Mar Vista U.S. Quality</p><p>&#128313; Generac Holdings, Inc. (GNRC US) by Ariel Mid Cap Value</p><p>&#128313; Hamamatsu Photonics (6965 JP) by Oakmark Global Fund</p><p>&#128313; Howard Hughes Holdings Inc. (HHH US) by Symmetry Invest</p><p>&#128313; IMCD N.V. (IMCD NA) by Fiduciary Management</p><p>&#128313; Intuit Inc. (INTU US) by WS Lindsell Train North American Equity Fund</p><p>&#128313; Jack Henry &amp; Associates, Inc. (JKHY US) by Riverwater Sustainable Value Strategy</p><p>&#128313; Keysight Technologies, Inc. (KEYS US) by Ariel Mid Cap Value</p><p>&#128313; Kuaishou Technology (1024 HK) by Ariel Emerging Markets Value</p><p>&#128313; Leggett &amp; Platt, Inc. (LEG US) by Riverwater Sustainable Value Strategy</p><p>&#128313; LSB Industries, Inc. (LXU US) by Riverwater Micro Opportunities</p><p>&#128313; Medical Facilities Corp. (DR CN) by Greystone Capital Partners</p><p>&#128313; MGM Resorts International (MGM US) by Symmetry Invest</p><p>&#128313; Minor International PCL (MINT TB) by Oakmark International Small Cap Fund</p><p>&#128313; PHI Group (PHIG US) by Cedar Creek Partners</p><p>&#128313; Rayonier, Inc. (RYN US) by Longleaf Partners Fund</p><p>&#128313; Red Violet, Inc. (RDVT US) by Riverwater Micro Opportunities</p><p>&#128313; Roku, Inc. (ROKU US) by Saga Partners</p><p>&#128313; Salesforce (CRM US) by Oakmark Global Select Fund</p><p>&#128313; SAP SE (SAP GY) by Oakmark International Fund</p><p>&#128313; Sprout Social (SPT US) by Pernas Research</p><p>&#128313; Steele Bancorp (STLE US) by Cedar Creek Partners</p><p>&#128313; The Walt Disney Company (DIS US) by KNA Capital</p><p>&#128313; Xiamen Faratronic Co., Ltd. (600563 CH) by Ariel International DM EM</p><div><hr /></div><h3><strong>AJ Bell plc $AJB LN by Vltava Fund</strong></h3><p><strong>Thesis:<br /><br /></strong>AJ Bell is a scalable UK investment platform benefiting from the shift to lower-cost online investing, with high margins and capital-light economics.</p><p><strong>Source</strong>: https://drive.google.com/file/d/181yEPa06iTNo7tjlor3ckhOuAddVLpQa/view?usp=drivesdk</p><p><strong>Analysis:<br /><br /></strong>AJ Bell is a British investment platform that enables individual investors to manage their savings and investments online. Through its services, AJ Bell provides clients access to a wide range of investment instruments, primarily stocks, funds, and retirement products. The company operates mainly in the United Kingdom and serves both retail investors and financial advisors. Its business model is founded primarily on fees for account management, trading, and administration. Thanks to its digital platform and low operating costs, AJ Bell can easily scale up by growing the number of its clients and volume of their assets under management. The company is benefiting from the long-term trend of shifting investments from traditional financial institutions to lower-cost online platforms and from households&#8217; growing interest in self-directed investing.<br /><br />From an investment perspective, Booking Holdings, AJ Bell, and Rightmove share several important characteristics. All operate as platforms that connect supply and demand while collecting fees or commissions for doing so. Meanwhile, they do not own the core assets that are sold by way of their services. Booking does not own hotels, Rightmove does not own real estate, and AJ Bell is not a traditional financial institution managing its own investment products. As a result, these are capital-light businesses with high margins and strong ability to generate free cash flow. At the same time, they benefit from network effects. The more users and partners their platforms have, the more valuable they are to all market participants. It is precisely this combination of dominant market position, low capital requirements, and high return on capital that makes them very attractive companies from an investment perspective. We have been tracking all three companies for quite some time, but it wasn&#8217;t until this year that their share prices reached levels that we found very attractive.</p><p><strong><a href="https://www.hfbestideas.com/?q=AJB+LN&amp;page=1">Access our full research database on AJ Bell plc</a></strong></p><div><hr /></div><h3><strong>AUB Group Limited $AUB AU by Ganes Focused Value Fund</strong></h3><p><strong>Thesis: </strong>AUB Group Limited reported profit and dividend growth, benefits from complex-risk brokerage and a high-margin Bizcover platform, continues UK acquisitions, and appears undervalued after AI-driven fears.</p><p><strong>Source</strong>: https://drive.google.com/file/d/1qUxtg4CkqsbpL067Js3_Ko02q_5W2Pvt/view?usp=drivesdk</p><p><strong>Analysis: </strong>AUB reported a healthy profit result for the half-year. Underlying profits were up 13.9% on the back of a 6.6% increase in revenue, they increased their dividend by 8% on the previous year, and indicated profits are likely to be up more than 10% for the full year. However, the shares were sold down more than 20% during the quarter. The company was swept up in the fear that AI will allow customers to bypass brokers and navigate the process of buying insurance directly from underwriters.<br /><br />While this is likely to happen for simple lines of insurance such as car insurance and home contents, it will be far more difficult when assessing specialised and complex risks for business owners, AUB&#8217;s typical client. And for simpler risks AUB already has the Bizcover platform which reported that revenues were up 13% on the prior year and profits were up 23%. Bizcover only represents 10% of the overall profits of AUB but it is the most profitable part of the business with margins of 46%, up from 37% a few years ago. And it already uses AI within its business processes, so it&#8217;s clear that AI also offers benefits, not just risks.<br /><br />The company also announced the acquisition of Prestige for $432m during the quarter. Prestige is a broking and underwriting agency business in the UK with net revenue of approximately $100m and this will be their fourth acquisition in the UK in recent years.<br /><br />It is hard to believe that only a few months ago the company received a takeover offer for $45 per share, and after reporting an increase in profits, increasing their dividend, and predicting profit growth the share price is down nearly 50%.</p><p><strong><a href="https://drive.google.com/file/d/1qUxtg4CkqsbpL067Js3_Ko02q_5W2Pvt/view?usp=drivesdk">Access our full research database on AUB Group Limited</a></strong></p><div><hr /></div><h3><strong>Bayer AG $BAYN GY by Ariel Global</strong></h3><p><strong>Thesis:<br /><br /></strong>Bayer AG is a life sciences leader with potential upside from litigation resolution and a strengthening pharma pipeline, marking the early stages of a turnaround.</p><p><strong>Source</strong>: https://drive.google.com/file/d/1sMukOoWD33ugRnCMUS2UMkujTXkU_8Dk/view?usp=drivesdk</p><p><strong>Analysis:<br /><br /></strong>We purchased leader in life sciences, healthcare and agriculture, Bayer AG, during the quarter. We believe the market remains anchored to the company&#8217;s past challenges and is overlooking several catalysts that could materially improve the company&#8217;s outlook. The stock has been weighed down for years by Roundup litigation, uneven crop protection trends and a disappointing drug pipeline. Looking ahead, Bayer&#8217;s late-stage medicine Asundexian is showing encouraging results, and we believe a potential U.S. Supreme Court review of a key glyphosate case could pave the way for resolving most outstanding lawsuits, easing financial pressure and removing a major overhang. We think Bayer is entering the early stages of a turnaround and as legal risks diminish and the pharma pipeline strengthens, the stock has meaningful upside.</p><p><strong><a href="https://www.hfbestideas.com/?q=BAYN+GY&amp;page=1">Access our full research database on Bayer AG</a></strong></p><div><hr /></div><h3><strong>Becle S.A.B. de C.V. $CUERVO* MM by Longleaf Partners Small Cap Fund</strong></h3><p><strong>Thesis:<br /><br /></strong>Becle is a leading spirits company positioned for 2027+ growth, with financial strength and focus on fast-growing tequila amid potential industry consolidation.</p><p><strong>Source</strong>: https://drive.google.com/file/d/1iqPc242wXEV5lbqcyZqUgeCa9YaRooZ2/view?usp=drivesdk</p><p><strong>Analysis:<br /><br /></strong>Becle &#8211; Spirits company Becle detracted after the company reported a quarter that the stock market did not like. This short-term earnings volatility (on a business that is 200+ years old) was driven by a shift in distribution that is the right thing to do for the long-term. While this means that reported revenues will be down a few percent in 2026, this sets the company up for growth in 2027 and beyond. As mentioned above on Boston Beer, industry trends did not get worse, but there remains debate about spirits consumption going forward. The biggest industry news came late in the quarter when it was confirmed that Pernod Ricard and Brown-Forman were discussing a merger. The industry is ripe for consolidation, and now this could be kicking off. Becle will be poised to act from a position of financial strength while being focused on the still fastest growing part of the spirits industry, tequila. We added to our position in the quarter after the stock declined.</p><p><strong><a href="https://drive.google.com/file/d/1iqPc242wXEV5lbqcyZqUgeCa9YaRooZ2/view?usp=drivesdk">Access our full research database on Becle S.A.B. de C.V.</a></strong></p><div><hr /></div><h3><strong>Bio-Rad Laboratories Inc. $BIO US by Ariel Focused Value</strong></h3><p><strong>Thesis:<br /><br /></strong>Bio-Rad Laboratories Inc. is a global life sciences tools leader with rising margins, high recurring revenue, and dominant market positions supporting long-term growth.</p><p><strong>Source</strong>: https://drive.google.com/file/d/18DqwEqY5Uq4y_iPdbwrP7NhGBTNGm6OO/view?usp=drivesdk</p><p><strong>Analysis:<br /><br /></strong>Additionally, we repurchased Bio-Rad Laboratories Inc. (BIO), a global leader in laboratory equipment and biological testing. Bio-Rad benefits from a well diversified geographic and end market footprint, with balanced exposure across clinical diagnostics, biopharma, academic research and applied markets. We believe the company&#8217;s financial profile is attractive, characterized by rising operating margins and a high proportion of recurring revenue sales. We view Bio-Rad as a classic Ariel business, supported by strong innovation, global scale and leadership positions across much of its portfolio. Management estimates nearly 80% of sales are derived from categories where Bio-Rad holds dominant market share. Given these competitive advantages, we think the company is well-positioned to generate sustainable growth and long-term shareholder value in a steadily expanding global life sciences market.</p><p><strong><a href="https://www.hfbestideas.com/?q=BIO+US&amp;page=1">Access our full research database on Bio-Rad Laboratories Inc.</a></strong></p><div><hr /></div><h3><strong>Coupang, Inc. $CPNG US by Oakmark International Fund</strong></h3><p><strong>Thesis:<br /><br /></strong>Coupang, Inc. is South Korea&#8217;s leading e-commerce platform with a vertically integrated logistics moat enabling share gains and margin expansion, now available at an attractive valuation post-cyber incident.</p><p><strong>Source</strong>: https://drive.google.com/file/d/117XsrKl37qC_8GBMUOEYJ5-0kV95iIC6/view?usp=drivesdk</p><p><strong>Analysis:<br /><br /></strong>Coupang is the leading e-commerce company in South Korea, often compared to Amazon for its wide product selection, strong customer service, and best in class logistics network. Founded in 2010, the company has built its reputation around its &#8220;Rocket WOW&#8221; system, which offers same-day or next-day shipping on millions of items. What differentiates this service is Coupang&#8217;s deeply vertically integrated logistics model. Rather than relying primarily on third-party sellers and carriers, the company owns and operates its fulfillment centers, manages inventory directly, and controls last-mile delivery through its own network. We believe this advantage positions it well to capture market share and expand margins over the long term. Despite Coupang&#8217;s e-commerce dominance, its share price has fallen significantly since last November after a cyber breach. We continue to monitor the fallout from the cyber incident but believe this has given us an opportunity to invest in a high-quality company at an attractive valuation.</p><p><strong><a href="https://www.hfbestideas.com/?q=CPNG+US&amp;page=1">Access our full research database on Coupang, Inc.</a></strong></p><div><hr /></div><h3><strong>Cushman &amp; Wakefield plc $CWK US by Riverwater Small Cap Strategy</strong></h3><p><strong>Thesis: </strong>Cushman &amp; Wakefield is a global CRE services firm with a durable, recurring-revenue moat and attractive valuation where AI disintermediation fears appear overstated.</p><p><strong>Source</strong>: https://drive.google.com/file/d/1Hgz41pHkb0TbkrB7L8Gwa7JLwYXJ4pQo/view?usp=drivesdk</p><p><strong>Analysis: </strong>Holdings Deep Dive: Cushman &amp; Wakefield (CWK) An AI-Driven Selloff Creates Opportunity Cushman &amp; Wakefield (NYSE: CWK) is one of the world&#8217;s largest commercial real estate (CRE) services firms, operating in over 60 countries with approximately 52,000 employees. The company provides a comprehensive suite of services&#8212;leasing, capital markets advisory, property and facilities management, and valuation&#8212;to both occupiers and investors across the office, industrial, retail, life sciences, and data center sectors. Despite strong operational fundamentals and an improving earnings trajectory, CWK shares have traded under persistent pressure due to market concerns that artificial intelligence and technology-driven platforms could disintermediate traditional CRE service providers. We believe this fear is significantly overstated. CEO Michelle MacKay has emphasized that Cushman&#8217;s key differentiator lies in delivering &#8220;tailored, bespoke solutions&#8221; through deep client relationships and human expertise&#8212;capabilities that cannot be easily replicated by a generic algorithm. The company&#8217;s relationship-driven advisory model, particularly in leasing and capital markets, depends on nuanced local market knowledge, negotiation skill, and trust&#8212;attributes where AI augments rather than replaces the human element. Durable Competitive Moat CWK possesses a meaningful moat rooted in its global scale, diversified service platform, and entrenched client relationships. Over 53% of the firm&#8217;s fee revenue comes from Property, Facilities &amp; Project Management (PFPM)&#8212;a contract-based, annuity-like business secured through multi-year agreements on a fixed-fee or cost-plus basis. This recurring revenue base provides substantial earnings visibility and creates high switching costs, as institutional occupiers and investors are reluctant to transition the management of large, mission-critical real estate portfolios to untested providers. In the transactional businesses (leasing and capital markets), barriers to entry are equally formidable: brand reputation, regulatory compliance, deep broker networks, and the ability to respond to multinational RFP standards all favor incumbents. A Consolidated Industry Favoring Scale The global CRE services industry is highly consolidated, dominated by three firms&#8212;CBRE, JLL, and Cushman &amp; Wakefield&#8212;that collectively command the vast majority of institutional mandates and cross-border transactions. This oligopolistic structure creates significant advantages for incumbents: large corporate occupiers and institutional investors strongly prefer working with firms that can service their portfolios across geographies and asset classes from a single platform. For a new entrant, replicating the global infrastructure, talent bench, and data capabilities of these established players would require enormous capital and years of investment. While technology-enabled platforms like CoStar and VTS have carved out niche roles in data and analytics, they have not penetrated the advisory, brokerage, or management businesses where CWK&#8217;s full-service value proposition is most difficult to displace. The consolidated nature of the industry also provides pricing discipline and limits the risk of destructive competition, which supports margin stability over the cycle. Compelling Valuation With Multiple Catalysts At its December 2025 Investor Day, Cushman &amp; Wakefield outlined a 2026&#8211;2028 financial framework that includes 6&#8211;8% organic fee revenue growth, 15&#8211;20% annual adjusted EPS growth, 60&#8211;80% free cash flow conversion, 150 bps of adjusted EBITDA margin expansion by year-end 2028, and net leverage of 2x by year-end 2028. Management also said that this framework should translate into roughly $800 million of cumulative free cash flow through 2028, supporting continued deleveraging and reinvestment. In its February 2026 full-year 2025 earnings release, the company reported adjusted EBITDA of $656.2 million, free cash flow of $293.0 million, and noted that it prepaid $300 million of debt during 2025. Not only does CWK trade at a significant discount to peers but also a discount to its historical valuation, while in our view business is improving.</p><p><strong><a href="https://drive.google.com/file/d/1Hgz41pHkb0TbkrB7L8Gwa7JLwYXJ4pQo/view?usp=drivesdk">Access our full research database on Cushman &amp; Wakefield plc</a></strong></p><div><hr /></div><h3><strong>DTS Corporation $9682 JP by Oakmark International Small Cap Fund</strong></h3><p><strong>Thesis:<br /><br /></strong>DTS Corporation is a leading Japanese systems integrator trading at a discount despite strong digitization tailwinds and expected earnings acceleration as investments taper.</p><p><strong>Source</strong>: https://drive.google.com/file/d/19ITh6U8WGs5up_NJ4rcjnODU2M1gs9NR/view?usp=drivesdk</p><p><strong>Analysis:<br /><br /></strong>DTS is a leading systems integrator in Japan, helping companies modernize IT systems from manual, on-premise environments to automated, digital, and cloud-based platforms. The company has a long operating history and deep relationships with large enterprise customers, particularly in financial services, telecom, and manufacturing. Japanese system integrators (SI) benefit from powerful structural tailwinds as the country remains well behind other developed markets in digitization, driving a multi-year increase in IT investment. A structural shortage of IT engineers and a strong preference for onshore talent further support favorable industry dynamics. Despite these fundamentals, DTS trades at a meaningful discount to our estimate of its intrinsic value due to short-term earnings sentiment and elevated investment spending. As the company nears the end of its investment cycle, we expect earnings to accelerate and valuation to re-rate with improving operating leverage.</p><p><strong><a href="https://www.hfbestideas.com/?q=9682+JP&amp;page=1">Access our full research database on DTS Corporation.</a></strong></p><div><hr /></div><h3><strong>ENGIE SA $ENGI FP by Ariel Global</strong></h3><p><strong>Thesis: </strong>ENGIE SA is a diversified utility with increased exposure to stable regulated earnings via UKPN, plus upside from storage, deleveraging, and renewables.</p><p><strong>Source</strong>: https://drive.google.com/file/d/1sMukOoWD33ugRnCMUS2UMkujTXkU_8Dk/view?usp=drivesdk</p><p><strong>Analysis: </strong>We added ENGIE SA, a globally integrated utility with operations spanning power generation, regulated networks and energy retail. The company&#8217;s recent acquisition of UK Power Networks (UKPN) increases its weighting toward regulated electricity distribution and we believe this enhances the stability of its earnings profile. Meanwhile, we think the growth in UKPN&#8217;s regulated asset base is not yet fully reflected in market expectations. ENGIE also maintains a strong position in battery energy storage which, in our view, offers an additional avenue for value creation. Over time, deleveraging is expected to provide greater financial flexibility to support expansion across regulated and storage businesses. In parallel, a firmer European energy backdrop and continued investment in renewables may provide incremental support.</p><p><strong><a href="https://www.hfbestideas.com/?q=ENGI+FP&amp;page=1">Access our full research database on ENGIE SA</a></strong></p><div><hr /></div><h3><strong>FactSet Research Systems Inc. $FDS US by Ariel Focused Value</strong></h3><p><strong>Thesis: </strong>FactSet Research Systems Inc. is an embedded financial data and analytics provider with high switching costs and recurring revenues poised to benefit from AI-driven efficiencies.</p><p><strong>Source</strong>: https://drive.google.com/file/d/18DqwEqY5Uq4y_iPdbwrP7NhGBTNGm6OO/view?usp=drivesdk</p><p><strong>Analysis: </strong>Also during the quarter, we initiated a position in FactSet Research Systems (FDS), a leading provider of information and analytics to the global financial services industry. FactSet&#8217;s data and tools are deeply embedded in both buy-side and sell-side workflows, creating exceptionally high switching costs. Meanwhile, its aggregated and rigorously curated data sets are difficult to replicate and highly scalable across clients and use cases. Shares have faced significant pressure amid concerns that slowing growth and margin compression signal AI related disruption; however, we believe these fears are overstated. In our view, FactSet&#8217;s highly predictable, recurring revenue model and strong cash generation position the company to benefit from AI through enhanced analytics, workflow efficiency and internal productivity gains. We believe the company&#8217;s durable competitive advantages support an attractive long-term return profile at current valuation levels.</p><p><strong><a href="https://www.hfbestideas.com/?q=FDS+US&amp;page=1">Access our full research database on FactSet Research Systems Inc.</a></strong></p>
<p>
<a href="https://stockanalysiscompilation.substack.com/p/hedge-funds-best-ideas-93-q126-pitches">
Read more
</a>
</p>